FDA Drug Recalls

Recalls / Class III

Class IIID-0118-2017

Product

Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.

Affected lot / code info
Lot #: 1136091A, Incorrectly Labeled Exp: 03/18

Why it was recalled

Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.

Recalling firm

Firm
Actavis Laboratories, FL, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
4955 Orange Dr, Davie, Florida 33314-3902

Distribution

Quantity
15,984 bottles
Distribution pattern
Nationwide and Puerto Rico

Timeline

Recall initiated
2016-08-30
FDA classified
2016-11-01
Posted by FDA
2016-11-09
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0118-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.